Lab Home | Phone | Search | ||||||||
|
||||||||
In the past several years, halogen bonds have been shown to be relevant in crystal engineering and biomedical applications. One of the reasons for the utility of these types of noncovalent interactions in the development of, for example, pharmaceutical ligands is that their strengths and geometric properties are very tunable. That is, substitution of atoms or chemical groups in the vicinity of a halogen can have a very strong effect on the strength of the halogen bond. In this study we investigate halogen-bonding interactions involving aromatically-bound halogens (Cl, Br, and I) and a carbonyl oxygen. The properties of these halogen bonds are modulated by substitution of aromatic hydrogens with fluorines, which are very electronegative. It is found that these types of substitutions have dramatic effects on the strengths of the halogen bonds, leading to interactions that can be up to 100% stronger. Very good correlations are obtained between the interaction energies and the magnitudes of the positive electrostatic potentials (σ-holes) on the halogens. We also investigate interactions of several modified tetrabromobenzoimidazole derivatives with the protein kinase CK2, which promotes cell survival and is involved in the survival of tumor cells. Tetrabromobenzoimidazole is an inhibitor of CK2 whose mode of interaction involves a strong halogen bond. Host: Mike Wall, mewall@lanl.gov |